Boston Bio Systems has informed that Board of directors of the company at its meeting held on Thursday, November 14, 2024, has considered and approved Standalone un-audited financial results of the company for the quarter and half year ended September 30, 2024. A copy of said results along with the Limited Review report of the Statutory Auditors is attached as ‘Annexure A’,
The above information is a part of company’s filings submitted to BSE.